Estimating Preferences for Treatments in Patients With Localized Prostate Cancer  Mónica Ávila, MPH, Virginia Becerra, MPH, Ferran Guedea, MD, PhD, José.

Presentación del tema: "Estimating Preferences for Treatments in Patients With Localized Prostate Cancer  Mónica Ávila, MPH, Virginia Becerra, MPH, Ferran Guedea, MD, PhD, José."— Transcripción de la presentación:

1 Estimating Preferences for Treatments in Patients With Localized Prostate Cancer 
Mónica Ávila, MPH, Virginia Becerra, MPH, Ferran Guedea, MD, PhD, José Francisco Suárez, MD, Pablo Fernandez, MD, Víctor Macías, MD, PhD, Alfonso Mariño, MD, Asunción Hervás, MD, PhD, Ismael Herruzo, MD, PhD, María José Ortiz, MD, PhD, Javier Ponce de León, MD, PhD, Gemma Sancho, MD, PhD, Oriol Cunillera, MSc, Yolanda Pardo, PhD, Francesc Cots, PhD, Montse Ferrer, MD, PhD Jordi Alonso, Olatz Garín, Angels Pont, Ana Boladeras, Ferran Ferrer, Ferran Guedea, Evelyn Martínez, Joan Pera, Montse Ventura, Ferran Aguiló, Manel Castells, Humberto Villavicencio, Jordi Craven-Bratle, Belen de Paula, Benjamin Guix, Helena Hernández, Víctor Muñoz, Alfredo Ramos, Pedro J. Prada Mónica Ávila, MPH, Virginia Becerra, MPH, Ferran Guedea, MD, PhD, José Francisco Suárez, MD, Pablo Fernandez, MD, Víctor Macías, MD, PhD, Alfonso Mariño, MD, Asunción Hervás, MD, PhD, Ismael Herruzo, MD, PhD, María José Ortiz, MD, PhD, Javier Ponce de León, MD, PhD, Gemma Sancho, MD, PhD, Oriol Cunillera, MSc, Yolanda Pardo, PhD, Francesc Cots, PhD, Montse Ferrer, MD, PhD Jordi Alonso, Olatz Garín, Angels Pont, Ana Boladeras, Ferran Ferrer, Ferran Guedea, Evelyn Martínez, Joan Pera, Montse Ventura, Ferran Aguiló, Manel Castells, Humberto Villavicencio, Jordi Craven-Bratle, Belen de Paula, Benjamin Guix, Helena Hernández, Víctor Muñoz, Alfredo Ramos, Pedro J. Prada  International Journal of Radiation Oncology • Biology • Physics  Volume 91, Issue 2, Pages (February 2015) DOI: /j.ijrobp Copyright © 2015 Elsevier Inc. Terms and Conditions

2 Fig. 1 Distribution of patients' symptom severity at the end of follow-up according to baseline symptom severity (pretreatment evaluation). Percentage values in the bars represent the proportion of patients who reported problems at the end of follow-up. White bars show stable patients; green bars show those who improved from baseline; and light and dark red bars show those with slight and severe side effects, respectively. A color version of this figure is available at International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp ) Copyright © 2015 Elsevier Inc. Terms and Conditions